Hospitals Buy Your Insulin Cheap—Then Bill You Full Price

Your hospital buys insulin at half price. Then it bills you full price. And it keeps the difference. This isn't a glitch. It's a feature — built into a federal program called 340B.

What Is the 340B Drug Pricing Program?

The 340B program was created to help low-income patients get affordable medications. It lets qualifying hospitals buy drugs at 25% to 50% below the standard list price. Insulin, cancer drugs, specialty medications — all available at steep discounts.

Sounds like a win for patients, right?

Here's what actually happens. Those same hospitals turn around and bill you — and your insurance company — the full list price. They pocket the difference. No disclosure. No discount passed along. Just profit.

How Bad Is the Markup?

Studies have found cancer drug markups at 340B hospitals exceeding 600% above what the hospital actually paid. That's not a rounding error. That's a business model.

The Government Accountability Office (GAO) looked into whether these hospitals were using 340B savings to help low-income patients — the people the program was designed for. The finding? Less than half of 340B hospitals pass any savings along to those patients at all.

The program isn't broken. It's working exactly as the insiders designed it.

Why Your Insurance Makes This Worse

Traditional insurance plans — HMOs, PPOs from carriers like Blue Cross, United, Cigna, Aetna, and Humana — give employees zero reason to shop for better prices. You hit your deductible, you pay your copay, and you move on. Nobody asks what the hospital actually paid for that drug. Nobody negotiates.

When no one shops, hospitals face no pressure to compete. Inflated prices stick. Premiums keep rising. And the cycle continues.

How Indemnity Plans Break the Cycle

This is exactly why The Benefit X-Change offers an employer-sponsored indemnity plan option alongside its ICHRA administration services.

Indemnity plans work differently. There are no deductibles and no copays. Instead, the plan pays a set benefit amount for covered services. If an employee finds a lower cash price — say, at a direct-pay clinic or a transparent surgery center like Dr. Keith Smith's Surgery Center of Oklahoma — they keep the difference.

That's a real financial incentive to shop. And when employees shop, they find that cash prices are often 50% to 80% lower than "network rates." Mark Cuban's Cost Plus Drugs has proven the same thing works for medications.

Real shopping creates real competition. Real competition drives prices down — for everyone.

Small Businesses Can Lead the Way

Small business owners don't have to play by the old rules. Through an ICHRA (Individual Coverage HRA), employers set a defined contribution amount and let employees choose their own health coverage. Employees who opt out of the ICHRA can instead access the employer-sponsored indemnity plan — putting them in the driver's seat as healthcare consumers.

The 340B scam thrives in the dark. Transparency — and the right benefit structure — brings it into the light.

Ready to stop overpaying and start giving your employees real choices? Visit benefitx.com to learn how The Benefit X-Change can help your small business build a smarter, more affordable benefits strategy in 2026.